Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
WORKING PAPERS
August 10, 2005
In this posthumously published working paper, Dick Sabot argues that the U.S. external deficit is putting at risk the welfare of poor people in developing countries. This accessible paper draws on a forthcoming book, The U.S. as a Debtor Nation, by William Cline, and has been updated to include Clin...
BRIEFS
July 20, 2005
Zimbabwe has experienced a precipitous collapse in its economy over the past five years. The government blames its economic problems on external forces and drought. We assess these claims, but find that the economic crisis has cost the government far more in key budget resources than has the donor p...
REPORTS
July 19, 2005
Making Markets for Vaccines: Ideas to Action presents the proposal from theory to practice, by showing how a commitment can be consistent with ordinary legal and budgetary principles. A draft contract term sheet is included, highlighting the key elements of a credible guarantee.
RICH WORLD, POOR WORLD
July 18, 2005
HIV/AIDS is one of the largest challenges facing the global community. The disease has reduced life expectancy by more than a decade in the hardest hit countries and slashed productivity, making it even harder for poor countries to escape poverty. Global HIV/AIDS and the Developing World, a CGD Ric...
RICH WORLD, POOR WORLD
July 18, 2005
Development refers to improvements in the conditions of people’s lives, such as health, education, and income. It occurs at different rates in different countries. The U.S. underwent its own version of development since the time it became an independent nation in 1776.
Learn more about Rich World...
BRIEFS
July 18, 2005
This Brief is based on the CGD book Millions Saved: Proven Successes in Global Health. The book book features 17 success stories. These cases describe some large-scale efforts to improve health in developing countries that have succeeded - saving millions of lives and preserving the livelihoods and...
BRIEFS
July 13, 2005
New medicines are usually financed by a mixture of public funding by governments, philanthropic giving, and investment by private firms. Private investment is especially important in paying for and managing the later stages of clinical trials, regulatory approval, and investment in manufacturing cap...